Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain
Gareth J SangerVolume:
141
Year:
2004
Language:
english
Pages:
10
DOI:
10.1038/sj.bjp.0705742
File:
PDF, 243 KB
english, 2004